Osisko Provides Board Update
MONTREAL, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (“Osisko” or the “Corporation”) (TSX and NYSE: OR) announces today that The Honourable Mr. John R. Baird has resigned as a director of the Corporation, effective immediately.
Mr. Baird was appointed to the Board as an independent board member in April 2020. During this time, The Hon. Mr. Baird served as Chair of the Governance and Nomination Committee. The Corporation thanks Mr. Baird for his many valuable contributions during his Board tenure and wishes him success in his future endeavors.
Mr. Norman MacDonald, Chair of Osisko’s Board of Directors commented: “John has been a key independent member of Osisko’s Board for almost 4 years, and over this period, the Corporation has benefitted greatly from his unique combination of knowledge and experience. On behalf of the Board, management and the Corporation’s shareholders, I would like to extend John all the best going forward.”
About Osisko Gold Royalties Ltd
Osisko Gold Royalties Ltd is an intermediate precious metal royalty company which holds a North American focused portfolio of over 180 royalties, streams and precious metal offtakes. Osisko’s portfolio is anchored by its cornerstone asset, a 3-5% net smelter return royalty on the Canadian Malartic mine, one of Canada’s largest gold mines.
Osisko’s head office is located at 1100 Avenue des Canadiens-de-Montréal, Suite 300, Montréal, Québec, H3B 2S2.
For further information, please contact Osisko Gold Royalties Ltd:
| Grant MoentingVice President, Capital Markets Tel: (514) 940-0670 #116Mobile: (365) 275-1954Email: [email protected] | Heather TaylorVice President, Sustainability & CommunicationsTel: (514) 940-0670 #105Email: [email protected] |
Source: Osisko Gold Royalties Ltd.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Manufacturing Foundation Behind AiMOGA and LUXEED: How Chery’s Capabilities Support Two Global Brands
- Bluerock Private Real Estate Fund Announces Monthly Distribution for November 2026
- TaiMed Biologics to Present 24-Week Phase 2a Data on TMB-365/TMB-380 Maintenance Regimen at HIV Glasgow 2026
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share